| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/23/2008 | US20080261890 Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions |
| 10/23/2008 | US20080261889 Using variation in mannan-binding lectin (MBL) gene as diagnostic/prognostic indicator; Alzheimer's disease |
| 10/23/2008 | US20080261888 Platelet-derived growth factor-D (PDGF-D); stimulating cell proliferation, angiogensis |
| 10/23/2008 | US20080261887 Administering porcine circovirus type 2 (PCV2) antigen, such as recombinant baculovirus expressed ORF2 antigen to a pig; lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes |
| 10/23/2008 | US20080261886 For preventing and/or treating bleeding episodes |
| 10/23/2008 | US20080261885 Conglycinin fragments extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; metal affinity chromatography; treating with chymotrypsin; hyperlipidemia |
| 10/23/2008 | US20080261884 Human serum albumin, aldehyde cross-linker, and polyvinylpyrrolidone additive which accelerates crosslinking; for sealing bronchopleural fistula; emergency tamponade |
| 10/23/2008 | US20080261883 Runx3 gene showing anti-tumor activity and use thereof |
| 10/23/2008 | US20080261882 Methods for Inhibiting Heregulin and Treating Cancer |
| 10/23/2008 | US20080261881 Diluted in physiological saline, with or without the addition of human albumin or cyclodextrin |
| 10/23/2008 | US20080261880 Synthetic approach to designed chemical structures |
| 10/23/2008 | US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors |
| 10/23/2008 | US20080261878 In-vivo assay; tau protein; amyloid precursor proteins; neurodegenerative diseases |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261876 Method for Purifying Marine Collagen and the Processing Thereof Into Porous Sponges |
| 10/23/2008 | US20080261875 Method For Treating Cardiovascular Disease |
| 10/23/2008 | US20080261874 Point mutations; single or double alternation of tyrosine and aspartate residues; carcinoma; AIDS; gene therapy |
| 10/23/2008 | US20080261873 Growth-Hormone Secretagogues |
| 10/23/2008 | US20080261872 Use of Ghrelin and Unacylated Ghrelin Compositions in Insulin-Related Disease Conditions |
| 10/23/2008 | US20080261871 Y2/Y4 Selective Receptor Agonists for Therapeutic Interventions |
| 10/23/2008 | US20080261870 Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic Agent |
| 10/23/2008 | US20080261869 For treating bacterial and viral infections; kits |
| 10/23/2008 | US20080261868 Administering serine protease inhibitor such as antitrypsin; antiapoptosis; cancer, autoimmune disease, sepsis neurodegenerative disease, myocardial infarction, stroke, ischemia-reperfusion injury, toxin induced liver injury and AIDS |
| 10/23/2008 | US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 10/23/2008 | US20080261866 Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug |
| 10/23/2008 | US20080261865 Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders |
| 10/23/2008 | US20080261864 Insulin signalling pathway modulators, compounds influencing a dysregulated hepatic glucose production, pyruvate dehydrogenase kinase (PDHK) inhibitors, inhibitors of gastric emptying, insulin, inhibitors of GSK-3, retinoid X receptor (RXR) agonists, agonists of uncoupling protein |
| 10/23/2008 | US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use |
| 10/23/2008 | US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents |
| 10/23/2008 | US20080261861 2-Micron Family Plasmid and Use Thereof |
| 10/23/2008 | US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/23/2008 | US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins |
| 10/23/2008 | US20080261303 Method and medicament for inhibiting the expression of a given gene |
| 10/23/2008 | US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease |
| 10/23/2008 | US20080261277 Circularly permuted RNA molecule carrying a stabilized biologically active RNA; antisense RNA; gene expression inhbition; ribozyme |
| 10/23/2008 | US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 10/23/2008 | US20080261271 Expression of hiv polypeptides and production of virus-like particles |
| 10/23/2008 | US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers |
| 10/23/2008 | US20080261262 Lysis/Resealing Process and Device for Incorporating an Active Ingredient, in Particular Asparaginase or Inositol Hexaphosphate, in Erythrocytes |
| 10/23/2008 | US20080261260 Using actin binding protein expression as evaluative tool in diagnosing/prediciting gram-positive bacterial infection |
| 10/23/2008 | US20080261231 Nucleotide sequences coding angiotensinogen (AGT) gene for use as evaluative tool in diagnosing pancreatic disorders; disease screening through genomic variance |
| 10/23/2008 | US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260861 Modulating Lymphatic Function |
| 10/23/2008 | US20080260851 Comprised of acrylic acid or acrylamide; well dispersed in water due to their size, and can contain, encapsulate, incorporate, extract and release molecules, such as active molecules, agents, or ingredients, including bioactive molecules |
| 10/23/2008 | US20080260850 Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative |
| 10/23/2008 | US20080260847 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 10/23/2008 | US20080260840 glucagon-like peptide-1; osmotic drug delivery device and method |
| 10/23/2008 | US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent |
| 10/23/2008 | US20080260838 Pulmonary delivery of GLP in combination with diketopiperazine that is stable both in vitro and in vivo; diabetes, cancers, and obesity |
| 10/23/2008 | US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues |
| 10/23/2008 | US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery |
| 10/23/2008 | US20080260825 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
| 10/23/2008 | US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification |
| 10/23/2008 | US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta) |
| 10/23/2008 | US20080260804 Inhibiting microorganism adhesion and colonization on extended wear contact lenses; functionalizing and multilayer surface coupling such as polydiallyldimethylammonium chloride using polyacrylic acid and polyallylamine hydrochloride |
| 10/23/2008 | US20080260799 Controlled long term release of regeneration stimulants and healing agents to surrounding tissues; artificial joints, stents, dental restoratives |
| 10/23/2008 | US20080260798 Utilizing biocompatible, three dimensional cell growth promoting device containing alternating layers of A and S strips; providing preferential cellular attachment to active A strips rather than spacer S strips |
| 10/23/2008 | US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect |
| 10/23/2008 | US20080260787 Use of Collagen in Combination With Oxygen- and Ozone-Releasing Perfluorocarbons For the Preparation of a Medicament For the Treatment of Skin Lesions |
| 10/23/2008 | US20080260784 Compositions and Methods for Modulating an Immune Response |
| 10/23/2008 | US20080260769 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein |
| 10/23/2008 | US20080260766 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 10/23/2008 | US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins |
| 10/23/2008 | US20080260760 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders |
| 10/23/2008 | US20080260756 Peptide Inhibitors of iASPP |
| 10/23/2008 | US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia |
| 10/23/2008 | US20080260754 Prevent transplant rejection; autoimmune diseases |
| 10/23/2008 | US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease |
| 10/23/2008 | US20080260752 Prevention and reduction of blood loss |
| 10/23/2008 | US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders |
| 10/23/2008 | US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders |
| 10/23/2008 | US20080260743 Means and Methods for Detecting Methylated Dna |
| 10/23/2008 | US20080260742 Preventives/Remedies for Cancer |
| 10/23/2008 | US20080260734 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 10/23/2008 | US20080260727 Modulation of Nkg2d |
| 10/23/2008 | US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes |
| 10/23/2008 | US20080260719 EDG: Modulators of lymphocyte activation and migration |
| 10/23/2008 | US20080260715 Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 10/23/2008 | US20080260714 Nutrient mixture comprising fibrin, thrombin and a strontium-containing compound for use as therapeutic in bone healing or bone growth |
| 10/23/2008 | US20080260713 Neukinase, A Downstream protein of neuregulin |
| 10/23/2008 | US20080260712 Apparatus which enhances stability of invertebrate discs by reducing bending hysteresis of scoliotic spines; improving resistance of collagenous tissue to mechanical degradation |
| 10/23/2008 | US20080260711 Detoxifizyme with Activity of Transforming Aflatoxin and the Gene Encodes Thereof |
| 10/23/2008 | US20080260708 Nutrient broth for enhancing the body's innate ability to self-heal and self-regulate |
| 10/23/2008 | US20080260702 Using vector comprising nucleotide sequences coding neublastin as therapeutic treatment for vision defects |
| 10/23/2008 | US20080260691 Conjugated with amino acids, peptides, glycopeptides; bioavailability |
| 10/23/2008 | US20080260690 Viricidal protein for use in prevention and treatment of respiratory system infection |
| 10/23/2008 | US20080260689 Mixture comprising Interleukin receptor amino acid sequences for use in developing vaccine for prevention and treatment of autoimmune diseases; genetic vaccines |
| 10/23/2008 | US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea |
| 10/23/2008 | US20080260686 Methods of using il-31 to treat airway hyper-responsiveness and asthma |
| 10/23/2008 | US20080260685 Prodrugs of cc-1065 analogs |
| 10/23/2008 | US20080260684 Using cation exchange and hydrophobic interaction chromatography as tools in recovery of recombinant granulocyte-colony stimulating factor (G-CSF) |
| 10/23/2008 | US20080260675 Depolymerized Scleroglucan for Regulating and Improving the Moisture Content of the Skin |
| 10/23/2008 | US20080260654 Drug incorporated into carrier substrate of hyaluronic acid, amino acid or polyoxyalkylene glycol |
| 10/23/2008 | US20080260653 Topical chelation compounds; applying to skins of humans, animals |
| 10/23/2008 | US20080260650 Administering diagnostic agent and immunology moderator; detecting inflammed tissue |
| 10/23/2008 | US20080260644 Adjust concentration of chloride channel moderators within brain |
| 10/23/2008 | US20080260638 Receptor(sstr2)-selective somatostatin antagonists |